Overview

Tocilizumab Versus Baricitinib in Patients With Severe COVID-19

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare safety and effectiveness of tocilizumab and baricitinib in severe COVID-19.
Phase:
N/A
Details
Lead Sponsor:
University Hospital of Patras